20
Bcn Peptides Sa, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DESMOPRESSIN ACETATE, with a corresponding US DMF Number 19334.
Remarkably, this DMF maintains an Active status since its submission on April 06, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 23, 2014, and payment made on June 18, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II